Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Weight Outcomes in Adults Treated With Semaglutide s.c. 1.0 mg or 1.7 mg for Weight Management: a Non-interventional Cohort Study

NCT07627074 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07627074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07627074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Weight Outcomes in Adults Treated With Semaglutide s.c. 1.0 mg or 1.7 mg for Weight Management: a Non-interventional Cohort Study
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 12, 2026
Completion date
June 15, 2026
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight